M
Myriad Genetics, Inc. (MYGN)
NMS – Real vaqt narxi. Valyuta: USD
4.07
-0.14 (-3.33%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
4.07
-0.14 (-3.33%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Myriad Genetics, Inc., molekulyar diagnostika va aniq tibbiyot kompaniyasi bo'lib, molekulyar testlarni ishlab chiqadi. Kompaniya onkologiya, ayollar salomatligi va farmakogenomika uchun molekulyar diagnostika testlarini taklif etadi. Shuningdek, u irsiy saraton uchun DNK ketma-ketligini aniqlaydigan MyRisk Hereditary Cancer testini; metastatik ko'krak, tuxumdon, metastatik oshqozon osti bezi va metastatik prostata saratoni uchun DNK ketma-ketligini aniqlaydigan BRACAnalysis CDx Germline Companion Diagnostic testini; va tuxumdon saratoni bilan og'rigan bemorlarda gomologik rekombinatsiya etishmovchiligi holatini aniqlaydigan, o'simta uchun MyChoice CDx Companion Diagnostic testini taqdim etadi. Qo'shimcha ravishda, kompaniya prostata saratonining agressivligini baholash uchun RNK ekspressiyasi tahlilini o'tkazadigan Prolaris Prostate Cancer Prognostic testini; ko'krak saratonining agressivligini baholash uchun RNK ekspressiyasi testini EndoPredict Breast Cancer Prognostic; genomik profiling testini Precise Tumor Molecular Profile; homiladagi og'ir xromosom buzilishlarini skrining qilish uchun onaning qonidan foydalangan holda o'tkaziladigan invaziv bo'lmagan prenatal skrining testini Prequel Prenatal Screen; kelajakdagi ota-onalarga nasldan-naslga o'tadigan genetik kasallikni yuqtirish xavfini baholash uchun prenatal testni Foresight Carrier Screen; homilaning jinsini bashorat qiluvchi invaziv bo'lmagan qon testini SneakPeek Early Gender DNA test; FirstGene; va depressiya, xavotir, diqqat etishmasligi/giperaktivlik buzilishi va boshqa ruhiy salomatlik sharoitlari uchun psixotrop dori tanlashga yordam beradigan DNK genotiplash testini GeneSight Psychotropic Mental Health Medication testini taklif etadi. U Illumina, Inc.; Texas universiteti M.D. Anderson saraton markazi; Mayo tibbiy ta'lim va tadqiqot jamg'armasi; Boston bolalar tibbiyot markazi; Institut Curie va INSERM; va Eurobio Scientific SA bilan litsenziyalash hamkorligiga ega. Kompaniya 1991 yilda tashkil etilgan va shtab-kvartirasi Salt Leyk Siti, Yuta shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Dale Muzzey Ph.D. | Chief Scientific Officer |
| Dr. Patrick M. Burke Ph.D. | Executive Vice President of Innovation & Strategic Partnerships |
| Mr. Benjamin R. Wheeler | CFO & Principal Accounting Officer |
| Mr. Brian Donnelly | Chief Commercial Officer |
| Mr. Mark S. Verratti | Chief Operating Officer |
| Mr. Matthew Scalo | Senior Vice President of Investor Relations |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-06 | 10-Q | mygn-20260331.htm |
| 2026-05-05 | 8-K | mygn-20260505.htm |
| 2026-04-14 | DEF 14A | mygn-20260414.htm |
| 2026-03-02 | CORRESP | filename1.htm |
| 2026-02-24 | 10-K | mygn-20251231.htm |
| 2026-02-23 | 8-K | mygn-20260223.htm |
| 2026-01-12 | 8-K | mygn-20260112.htm |
| 2025-11-04 | 8-K/A | mygn-20251103.htm |
| 2025-11-03 | 8-K | mygn-20251103.htm |
| 2025-10-07 | 8-K | mygn-20251001.htm |
| Mr. Paul J. Diaz J.D. | Consultant |
| Mr. Samraat S. Raha | President, CEO & Director |
| Ms. Jennifer L. Fox J.D. | Chief Legal Officer |
| Ms. Shereen Solaiman | Chief People Officer |